BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31810585)

  • 21. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
    Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J
    Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.
    Zhao Y; Dai C; Wang M; Kang H; Lin S; Yang P; Liu X; Liu K; Xu P; Zheng Y; Li S; Dai Z
    Oncotarget; 2016 Sep; 7(39):62966-62975. PubMed ID: 27542234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.
    Zheng Y; Qin B; Li F; Xu S; Wang S; Li L
    Int J Clin Exp Med; 2015; 8(12):22382-92. PubMed ID: 26885218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
    Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
    BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.
    Zhao M; Liang F; Zhang B; Yan W; Zhang J
    Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
    Hu H; Cai W; Zheng S; Ge W
    Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
    Zhang JM; Wei K; Jiang M
    Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
    Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
    PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.
    Dong Z; Liu G; Huang B; Sun J; Wu D
    Int J Clin Exp Med; 2014; 7(12):5010-20. PubMed ID: 25664000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and clinicopathological significance of LOXL2 in cancers: A systematic review and meta-analysis.
    Zhang X; Huang J; You F; Li W; Zou Z
    J Cell Physiol; 2019 Nov; 234(11):21369-21379. PubMed ID: 31032923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis.
    Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG
    Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.
    Shen X; Wang J; Yan X; Ren X; Wang F; Chen X; Xu Y
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1285-302. PubMed ID: 27154175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
    Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic potential and prognostic significance of SOX2: A meta-analysis.
    Javaeed A; Ghauri SK
    World J Clin Oncol; 2019 Jun; 10(6):234-246. PubMed ID: 31367532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.